Nidah Shabbir Khakoo (Nidah S Khakoo)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Patients With Inflammatory Bowel Disease

Systemic Lupus Erythematosus

Top Venues

Current gastroenterology reports

Crohn's & colitis 360

Therapeutic advances in gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Shyam Vedantam, Erica Graff, Nabiha Shabbir Khakoo, Nidah Shabbir Khakoo, Michelle Pearlman
Food as Medicine: How to Influence the Microbiome and Improve Symptoms in Patients with Irritable Bowel Syndrome. Current gastroenterology reports 25 (3) (2023)
Shyam Vedantam, Erica Graff, Nabiha Shabbir Khakoo, Nidah Shabbir Khakoo, Michelle Pearlman
Food as Medicine: How to Influence the Microbiome and Improve Symptoms in Patients with Irritable Bowel Syndrome. Current gastroenterology reports 25 (3) (2023)
Shyam Vedantam, Erica Graff, Nabiha Shabbir Khakoo, Nidah Shabbir Khakoo, Michelle Pearlman
Food as Medicine: How to Influence the Microbiome and Improve Symptoms in Patients with Irritable Bowel Syndrome. Current gastroenterology reports (2023)
Oriana M Damas, Gabriela Kuftinec, Nidah Shabbir Khakoo, Diana Morillo, Maria A Quintero, James Levitt, Joanna Lopez, David H Kerman, Maria T Abreu, Amar R Deshpande, Seth J Schwartz, Ana Palacio
Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD. Therapeutic advances in gastroenterology 15 (2022)
Nidah Shabbir Khakoo, Ayanna Lewis, Giovanni A Roldan, Alex Al Khoury, Maria A Quintero, Amar R Deshpande, David H Kerman, Oriana M Damas, Maria T Abreu
Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel Disease. Crohn's & colitis 360 3 (3) (2021)
Nidah Shabbir Khakoo, Ayanna Lewis, Giovanni A Roldan, Alex Al Khoury, Maria A Quintero, Amar R Deshpande, David H Kerman, Oriana M Damas, Maria T Abreu
Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel Disease. Crohn's & colitis 360 3 (3) (2021)